𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pharmacokinetics of BW12C and mitomycin C, given in combination in a phase 1 study in patients with advanced gastrointestinal cancer

✍ Scribed by Ian F. Dennis; Jonathan R. S. Ramsay; Paul Workman; Norman M. Bleehen

Publisher
Springer
Year
1993
Tongue
English
Weight
560 KB
Volume
32
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A phase II study of combined 5-fluoroura
A phase II study of combined 5-fluorouracil and mitomycin C in advanced breast cancer
✍ Willy Mattsson; Finn Von Eyben; Lennart Hallsten; GΓΆran Bjelkengren πŸ“‚ Article πŸ“… 1982 πŸ› John Wiley and Sons 🌐 English βš– 340 KB πŸ‘ 2 views

In a Phase I1 study, 50 patients with advanced breast cancer were treated with a combination of 5fluorouracil(lOO0 mg/m2 on days 1 and 2) and mitomycin C (6 mg/m2 on day 2) (FuMi regimen). The courses were repeated every third to sixth week. Although 35 patients had previously received combination c

A phase II clinical trial of the combina
A phase II clinical trial of the combination mitomycin C, adriamycin, andcis-diamminedichloroplatinum in patients with advanced upper aerodigestive cancer
✍ Creagan, Edward T. ;Chang, Myron ;Long, Harry J. ;Rubin, Joseph πŸ“‚ Article πŸ“… 1986 πŸ› Wiley (John Wiley & Sons) βš– 517 KB

Twenty-seven patients with assessable, regionally advanced, or metastatic upper aerodigestive cancer of diverse histology received a combination of mitomycin C, adriamycin, and cisdiamminedichloroplatinum. All patients had previously received extensive surgery and/or radiation therapy. We observed a